换一批
换一批Population-based targeted sequencing of 54 candidate genes identifies <i>PALB2</i> as a susceptibility gene for high-grade serous ovarian cancer.
作者：
Honglin,Song [1]
;
Ed M,Dicks [1]
;
Jonathan,Tyrer [1]
;
Maria,Intermaggio [2]
;
Georgia,Chenevix-Trench [3]
;
David D,Bowtell [4]
;
Nadia,Traficante [5]
;
Aocs,Group [6]
;
James,Brenton [7]
;
Teodora,Goranova [7]
;
Karen,Hosking [1]
;
Anna,Piskorz [7]
;
Elke,van Oudenhove [8]
;
Jen,Doherty [9]
;
Holly R,Harris [10]
;
Mary Anne,Rossing [10]
;
Matthias,Duerst [11]
;
Thilo,Dork [12]
;
Natalia V,Bogdanova [13]
;
Francesmary,Modugno [14]
;
Kirsten,Moysich [15]
;
Kunle,Odunsi [16]
;
Roberta,Ness [17]
;
Beth Y,Karlan [18]
;
Jenny,Lester [18]
;
Allan,Jensen [19]
;
Susanne,Krüger Kjaer [20]
;
Estrid,Høgdall [21]
;
Ian G,Campbell [22]
;
Conxi,Lázaro [23]
;
Miguel Angel,Pujara [24]
;
Julie,Cunningham [25]
;
Robert,Vierkant [26]
;
Stacey J,Winham [26]
;
Michelle,Hildebrandt [27]
;
Chad,Huff [27]
;
Donghui,Li [27]
;
Xifeng,Wu [27]
;
Yao,Yu [27]
;
Jennifer B,Permuth [28]
;
Douglas A,Levine [29]
;
Joellen M,Schildkraut [30]
;
Marjorie J,Riggan [31]
;
Andrew,Berchuck [31]
;
Penelope M,Webb [32]
;
Opal Study,Group [32]
;
Cezary,Cybulski [33]
;
Jacek,Gronwald [33]
;
Anna,Jakubowska [34]
;
Jan,Lubinski [33]
;
Jennifer,Alsop [1]
;
Patricia,Harrington [1]
;
Isaac,Chan [2]
;
Usha,Menon [35]
;
Celeste L,Pearce [36]
;
Anna H,Wu [37]
;
Anna,de Fazio [38]
;
Catherine J,Kennedy [38]
;
Ellen,Goode [39]
;
Susan,Ramus [40]
;
Simon,Gayther [41]
;
Paul,Pharoah [42]
作者单位：
Department of Oncology, University of Cambridge, Cambridge, Cambridgeshire, UK.
[1]
School of Women's and Children's Health, Faculty of Medicine, University of New South Wales, Sydney, New South Wales, Australia.
[2]
Cancer Genetics, Queensland Institute of Medical Research-QIMR, Herston, Queensland, Australia.
[3]
Cancer Genomics and Genetics and Women's Cancer Programs, Peter MacCallum Cancer Centre, Melbourne, Victoria, Australia.
[4]
Sir Peter MacCallum Department of Oncology, The University of Melbourne, Melbourne, Victoria, Australia.
[5]
QIMR Berghofer Department of Genetics and Computational Biology, Herston, Queensland, Australia.;Department of Research, Peter MacCallum Cancer Centre, Melbourne, Victoria, Australia.
[6]
Cancer Research UK Cambridge Institute, University of Cambridge, Cambridge, Cambridgeshire, UK.
[7]
Laura and Isaac Perlmutter Cancer Center, New York University, New York, New York, USA.
[8]
Huntsman Institute, University of Utah, Salt Lake City, Utah, USA.
[9]
Division of Public Health Sciences, Fred Hutchinson Cancer Research Center, Seattle, Washington, USA.;Department of Epidemiology, University of Washington, Seattle, Washington, USA.
[10]
Department of Gynaecology, Jena University Hospital, Friedrich Schiller University Jena, Jena, Thüringen, Germany.
[11]
Gynaecology Research Unit, Hannover Medical School, Hannover, Niedersachsen, Germany.
[12]
Department of Radiation Oncology, Hannover Medical School, Hannover, Niedersachsen, Germany.;Department of Gynaecology, NN Alexandrov National Cancer Centre, Minsk, Minsk, Belarus.
[13]
Womens Cancer Research Center, Magee-Womens Research Institute, Pittsburgh, Pennsylvania, USA.;Department of Obstetrics, Gynecology and Reproductive Sciences, University of Pittsburgh School of Medicine, Pittsburgh, Pennsylvania, USA.
[14]
Division of Cancer Prevention and Control, Roswell Park Cancer Institute, Buffalo, New York, USA.
[15]
Department of Gynecologic Oncology, Roswell Park Cancer Institute, Buffalo, New York, USA.
[16]
School of Public Health, University of Texas Health Science Center at Houston, Houston, Texas, USA.
[17]
Department of Obstetrics and Gynecology, David Geffen School of Medicine, University of California Los Angeles, Los Angeles, California, USA.;Women's Cancer Program at the Samuel Oschin Comprehensive Cancer Institute, Cedars-Sinai Medical Center, Los Angeles, California, USA.
[18]
Department of Virus, Lifestyle and Genes, Danish Cancer Society Research Center, Kobenhavn, Denmark.
[19]
Department of Gynaecology, Rigshospitalet, University of Copenhagen, Kobenhavn, Denmark.
[20]
Department of Virus, Lifestyle and Genes, Danish Cancer Society Research Center, Kobenhavn, Denmark.;Department of Pathology, Herlev Hospital, University of Copenhagen, Kobenhavn, Denmark.
[21]
Sir Peter MacCallum Department of Oncology, The University of Melbourne, Melbourne, Victoria, Australia.;Department of Research, Cancer Genomics and Genetics, Peter MacCallum Cancer Centre, Melbourne, Victoria, Australia.
[22]
Hereditary Cancer Program, Catalan Institute of Oncology, Barcelona, Catalunya, Spain.
[23]
Translational Research Laboratory, Catalan Institute of Oncology, Barcelona, Catalunya, Spain.
[24]
Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, Minnesota, USA.
[25]
Department of Health Science Research, Division of Biomedical Statistics and Informatics, Mayo Clinic, Rochester, Minnesota, USA.
[26]
Department of Epidemiology, University of Texas MD Anderson Cancer Center, Houston, Texas, USA.
[27]
Department of Cancer Epidemiology, Moffitt Cancer Center, Tampa, Florida, USA.
[28]
Department of Surgery, Memorial Sloan Kettering Cancer Center, New York, New York, USA.;Gynecologic Oncology, Laura and Isaac Pearlmutter Cancer Center, New York University, New York, New York, USA.
[29]
Department of Public Health Sciences, University of Virginia, Charlottesville, Virginia, USA.
[30]
Department of Gynecologic Oncology, Duke University Hospital, Durham, North Carolina, USA.
[31]
Population Health Department, QIMR Berghofer Medical Research Institute, Herston, Queensland, Australia.
[32]
Department of Genetics and Pathology, Pomeranian Medical University in Szczecin, Szczecin, Zachodniopomorskie, Poland.
[33]
Department of Genetics and Pathology, Pomeranian Medical University in Szczecin, Szczecin, Zachodniopomorskie, Poland.;Independent Laboratory of Molecular Biology and Genetic Diagnostics, Pomeranian Medical University in Szczecin, Szczecin, Zachodniopomorskie, Poland.
[34]
MRC Clinical Trials Unit, Institute of Clinical Trials & Methodology, University College London, London, London, UK.
[35]
Department of Epidemiology, University of Michigan School of Public Health, Ann Arbor, Michigan, USA.
[36]
Department of Preventive Medicine, Keck School of Medicine, University of Southern California, Los Angeles, California, USA.
[37]
Centre for Cancer Research, The Westmead Institute for Medical Research, The University of Sydney, Sydney, New South Wales, Australia.;Department of Gynaecological Oncology, Westmead Hospital, Westmead, New South Wales, Australia.
[38]
Department of Health Science Research, Division of Epidemiology, Mayo Clinic, Rochester, Minnesota, USA.
[39]
School of Women's and Children's Health, Faculty of Medicine, University of New South Wales, Sydney, New South Wales, Australia.;Kinghorn Cancer Centre, Garvan Institute of Medical Research, Darlinghurst, New South Wales, Australia.
[40]
Center for Bioinformatics and Functional Genomics and the Cedars Sinai Genomics Core, Cedars-Sinai Medical Center, Los Angeles, California, USA.
[41]
Department of Public Health and Primary Care, University of Cambridge, Cambridge, UK pp10001@medschl.cam.ac.uk.
[42]
主题词
病例对照研究(Case-Control Studies);女(雌)性(Female);疾病遗传易感性(Genetic Predisposition to Disease);遗传变异(Genetic Variation);人类(Humans);卵巢肿瘤(Ovarian Neoplasms);危险性评估(Risk Assessment)
DOI
10.1136/jmedgenet-2019-106739
PMID
32546565
发布时间
2024-09-06
- 浏览2
Journal of medical genetics
Journal of medical genetics
305-313页
相似文献
- 中文期刊
- 外文期刊
- 学位论文
- 会议论文
